S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
NYSE:EW

Edwards Lifesciences Earnings Date, Estimates, & History

$111.96
+3.48 (+3.21%)
(As of 12/6/2021 12:00 AM ET)
Add
Compare
Today's Range
$108.79
$113.10
50-Day Range
$106.37
$120.04
52-Week Range
$78.44
$123.27
Volume
2.64 million shs
Average Volume
2.45 million shs
Market Capitalization
$69.90 billion
P/E Ratio
47.64
Dividend Yield
N/A
Beta
1.06

Earnings Summary

Upcoming
Earnings Date
Jan. 26
Estimated

Actual EPS
(Oct. 27)
$0.54
Beat By $0.01

Consensus EPS
(Oct. 27)
$0.53

Last Year's Q4 EPS
(10/21/2020)
$0.51

Skip Charts & View Estimated and Actual Earnings Data

Edwards Lifesciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Edwards Lifesciences Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Edwards Lifesciences (NYSE:EW) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20216$0.45$1.65$0.67 
Q2 20216$0.50$1.74$0.74$0.540-0.600
Q3 20216$0.51$1.71$0.73$$0.500-$0.560
Q4 20215$0.45$0.56$0.53$$0.530-$0.590
FY 202123$1.91$5.66$2.66
Q1 20225$0.53$0.61$0.58 
Q2 20225$0.55$0.67$0.63 
Q3 20225$0.57$0.68$0.63 
Q4 20225$0.59$0.72$0.67 
FY 202220$2.24$2.68$2.50
Q1 20231$0.64$0.64$0.64 
Q2 20231$0.69$0.69$0.69 
Q3 20231$0.68$0.68$0.68 

EW Earnings Information

Edwards Lifesciences last issued its earnings data on October 27th, 2021. The medical research company reported $0.54 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.01. The business earned $1.31 billion during the quarter, compared to analysts' expectations of $1.32 billion. Its quarterly revenue was up 14.8% on a year-over-year basis. Edwards Lifesciences has generated $2.35 earnings per share over the last year ($2.35 diluted earnings per share) and currently has a price-to-earnings ratio of 47.6. Earnings for Edwards Lifesciences are expected to grow by 11.45% in the coming year, from $2.27 to $2.53 per share. Edwards Lifesciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 26th, 2022 based off prior year's report dates.

Edwards Lifesciences (NYSE:EW) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
1/26/2022
(Estimated)
        
10/27/20219/30/2021$0.53$0.54+$0.01$0.54$1.32 billion$1.31 billion    
7/29/20216/30/2021$0.55$0.64+$0.09$0.50$1.29 billion$1.38 billion    
4/19/20213/31/2021$0.47$0.54+$0.07$0.54$1.16 billion$1.22 billion  
1/26/202112/31/2020$0.53$0.50($0.03)$0.51$1.18 billion$1.19 billion  
10/21/20209/30/2020$0.45$0.51+$0.06$0.50$1.08 billion$1.14 billion  
7/23/20206/30/2020$0.15$0.34+$0.19$0.88$782.90 million$925.00 million    
4/23/20203/31/2020$0.43$0.5033+$0.0733$1.55$1.03 billion$1.13 billion  
1/30/2020Q4 2019$0.4967$0.4867($0.01)$1.60$1.15 billion$1.17 billion  
10/23/2019Q3$0.4067$0.47+$0.0633$1.52$1.04 billion$1.09 billion    
7/23/2019Q2$0.4433$0.46+$0.0167$1.62$1.04 billion$1.09 billion    
4/23/20193/31/2019$0.41$0.44+$0.03$1.46$989.87 million$993.00 million  
1/31/201912/31/2018$0.39$0.39$2.31$973.72 million$977.70 million
10/23/20189/30/2018$0.34$0.3567+$0.0167$1.08$927.56 million$906.60 million    
7/26/2018Q2 2018$0.3767$0.4133+$0.0367$1.16$968.32 million$972.00 million    
4/24/2018Q1 2018$0.37$0.4067+$0.0367$1.48$936.69 million$938.00 million  
2/1/2018Q4 2017$0.3033$0.3133+$0.01$1.71$868.45 million$888.50 million  
10/24/2017Q3 2017$0.2867$0.28($0.0067)$0.89$833.85 million$821.50 million
7/26/2017Q2 2017$0.2933$0.36+$0.0667$1.30$839.16 million$842.00 million
4/25/2017Q1 2017$0.2733$0.3133+$0.04$0.82$776.51 million$883.50 million
2/1/2017Q416$0.24$0.25+$0.01$0.77$760.85 million$767.70 million
10/25/2016Q316$0.2267$0.2267$0.71$749.14 million$739.40 million
7/26/2016Q216$0.2333$0.2533+$0.02$0.94$724.26 million$759.30 million
4/26/2016Q116$0.22$0.2367+$0.0167$0.76$664.53 million$697.30 million
2/2/2016Q415$0.2067$0.21+$0.0033$0.62$647.44 million$671.10 million
10/26/2015Q315$0.3267$0.3567+$0.03$0.54$598.29 million$615.00 million
7/28/2015Q215$0.35$0.3767+$0.0267$0.63$604.97 million$616.80 million
4/23/2015Q115$0.3467$0.3733+$0.0267$0.56$585.16 million$590.30 million
2/3/2015Q414$0.3167$0.3533+$0.0367$0.56$610.50 million$618.00 million  
10/23/2014Q314$0.24$0.2667+$0.0267$0.36$546.10 million$607.40 million  
7/29/2014Q214$0.2567$0.2933+$0.0367($1.67)$545.10 million$547.00 million  
4/24/2014Q114$0.23$0.2533+$0.0233$0.48$523.10 million$522.40 million  
2/3/2014Q4 2013$0.14$0.1533+$0.0133$0.58$533.82 million$536.00 million  
10/28/2013Q3 2013$0.11$0.1133+$0.0033$0.34$490.96 million$496.00 million  
7/25/2013Q2 2013$0.1267$0.1367+$0.01$0.41$514.59 million$517.20 million  
4/23/2013Q1 2013$0.1267$0.12($0.0067)$0.10$518.69 million$496.70 million  
2/4/2013Q4 2012$0.2567$0.2567$499.46 million$510.50 million  
10/19/2012$0.1867$0.1933+$0.0067  
7/24/2012$0.22$0.2233+$0.0033
4/24/2012Q1 2012$0.08$0.09+$0.01$0.26
2/2/2012$0.1967$0.2067+$0.01
10/19/2011$0.13$0.1267($0.0033)
7/21/2011$0.1667$0.1633($0.0033)
4/20/2011$0.14$0.17+$0.03
2/2/2011$0.1767$0.1833+$0.0067
10/25/2010Q3 2010$0.07$0.07$0.22
7/21/2010Q2 2010$0.0733$0.0767+$0.0033$0.22
4/20/2010Q1 2010$0.0667$0.0667$0.20
2/4/2010Q4 2009$0.07$0.07$0.22
10/21/2009Q3 2009$0.06$0.06$0.05
7/20/2009Q2 2009$0.0633$0.0667+$0.0033$0.20
4/27/2009Q1 2009$0.0567$0.06+$0.0033$0.10
2/3/2009Q4 2008$0.0633$0.0633$0.22
10/21/2008Q3 2008$0.0467$0.0467$0.14
7/22/2008Q2 2008$0.0533$0.0533$0.15
4/22/2008Q1 2008$0.04$0.0467+$0.0067$0.20
2/5/2008Q4 2007$0.0433$0.0467+$0.0033$0.21
(Earnings results data provided by Zacks Investment Research)












Edwards Lifesciences (NYSE:EW) Earnings Frequently Asked Questions

When is Edwards Lifesciences's earnings date?

Edwards Lifesciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 26th, 2022 based off last year's report dates. Learn more on EW's earnings history

Did Edwards Lifesciences beat their earnings estimates last quarter?

In the previous quarter, Edwards Lifesciences (NYSE:EW) reported $0.54 earnings per share (EPS) to beat the analysts' consensus estimate of $0.53 by $0.01. Learn more on EW's earnings details

How can I listen to Edwards Lifesciences's earnings conference call?

The conference call for Edwards Lifesciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Edwards Lifesciences's conference call transcript?

The conference call transcript for Edwards Lifesciences's latest earnings report can be read online. Read Transcript

How much revenue does Edwards Lifesciences generate each year?

Edwards Lifesciences (NYSE:EW) has a recorded annual revenue of $4.39 billion.

How much profit does Edwards Lifesciences generate each year?

Edwards Lifesciences (NYSE:EW) has a recorded net income of $823.40 million. EW has generated $2.35 earnings per share over the last four quarters.

What is Edwards Lifesciences's price-to-earnings ratio?

Edwards Lifesciences (NYSE:EW) has a trailing price-to-earnings ratio of 47.64 and a forward price-to-earnings ratio of 49.32. The price/earnings-to-growth ratio is 3.46.

What is Edwards Lifesciences's EPS forecast for next year?

Edwards Lifesciences's earnings are expected to grow from $2.27 per share to $2.53 per share in the next year, which is a 11.45% increase.

This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.